Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
3.5%
1w
1.4%
1m
4.0%
3m
11.8%
6m
23.7%
1y
27.8%
all
6.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,099 3.5%
987
1,233
Company Overview
Sales
1,159 Cr
Growth: 0.2%
Profit after Tax
313 Cr
Growth: -3.5%
Mid Cap
11,502 Cr
P/E: 37.0x
Industry P/E: 31.1x
Fundamentals
Sales (Cr) ₹ 1,159
Growth 0.2%
EBITDA 37.9%
P/S 9.9x
Dividend 0.6%
P/E 37.0x
Book Value ₹ 190
PEG Ratio 157.1x
ROE 16.5%
P/B 5.8x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (23 Indices) view more
Followers (1)
varsha96